TTOO News and Press, T2 Biosystems Inc. From 04/21/22

LEXINGTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the first quarter 2022 after market close on Th...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

T2 Biosystems (NASDAQ:TTOO) said Thursday the Biomedical Advanced Research and Development Authority (BARDA) will provide additional $4.4M in funding for the multiple-year cost-share contract between BARDA and TTOO. The total potential BARDA funding if all contract options are exercised is $6...

LEXINGTON, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Offi...

LEXINGTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it will host an Analyst and Investor Day on Tuesday, April 12, 2022, at 12:00pm ET. ...

The company has ramped up its revenues and instrument placements and also initiated T2Biothreat and T2Resistance Panel clinical trials. The war in Ukraine may accelerate updates regarding the T2Biothreat panel. Their international presence is increasing more rapidly than their U.S...

3 Hot Penny Stocks to Watch as the Market Fluctuates With another disappointing day of trading for penny stocks and blue chips, how can investors find stocks to buy that are worth it? Well, the short answer is that it can be difficult. However, with the right research and a consistent u...

T2 Biosystems, Inc. (TTOO) Q4 2021 Earnings Conference Call February 17, 2022, 16:30 ET Company Participants Philip Taylor - Gilmartin Group John Sperzel - Chairman & CEO John Sprague - CFO Brett Giffin - Chief Commercial Officer Conference Call Participants Mark Massaro - BTIG Benjamin H...

Shares of T2 Biosystems (NASDAQ:TTOO) are up 19% in post-market trading after reporting Q4 2021 earnings results that beat on the top and bottom lines. Also, fiscal year 2022 revenue guidance range it provided included the Street consensus. Revenue declined ~10% to ~$7M compared to ...

T2 Biosystems press release (NASDAQ:TTOO): Q4 GAAP EPS of -$0.07 beats by $0.03. Revenue of $6.98M (-10.3% Y/Y) beats by $1.58M. Shares +5.6%. The company expects FY2022 total revenue of $28M to $31M vs. consensus of $30.75M, including product revenue of $16M to $17M and research and contribu...